Position in AMGN
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$638,055
+$140,891 QoQ
Shares Held
1,762
+24.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#2,015
of 3,140 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Certified Advisory Corp holds $12,736,081 across 8 Drug Manufacturers - General names. AMGN ranks #6 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
16,212 | $4,117,361 | |
| 2 | LLY |
ELI LILLY & Co
|
3,249 | $3,896,948 | |
| 3 | ABBV |
AbbVie Inc.
|
7,683 | $1,933,350 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
6,732 | $850,520 | |
| 5 | MRK |
Merck & Co., Inc.
|
6,383 | $820,215 | |
| 6 | AMGN |
Amgen Inc
This page
|
1,762 | $638,055 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,692 | $270,353 | |
| 8 | PFE |
Pfizer Inc
|
8,691 | $209,279 |
All Filings in AMGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $638,055 | 1,762 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $497,164 | 1,413 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $506,348 | 1,547 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $441,925 | 1,566 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $434,729 | 1,557 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $447,697 | 1,437 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $388,353 | 1,490 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $473,648 | 1,470 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $456,177 | 1,460 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $357,958 | 1,259 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $358,296 | 1,244 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $340,779 | 7,904 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $283,297 | 1,276 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $315,967 | 1,307 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $590,152 | 2,247 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $499,486 | 2,216 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $322,859 | 1,327 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $311,947 | 1,290 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $290,211 | 1,290 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $274,318 | 1,290 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $299,568 | 1,229 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $305,787 | 1,229 | Shares | Sole | 2021-05-10 | |
| 2020-06-30 | $284,918 | 1,208 | Shares | Defined | 2020-07-27 | |
| 2020-03-31 | $204,351 | 1,008 | Shares | Defined | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||